Year archive

IMMUNIC, INC. — 2026 filings

All 29 regulatory filings released by IMMUNIC, INC. (IMUX) in 2026, sourced directly from the official regulator.

29 Filings

2026 Period

2026 filings (29)

Filing	Released	Lang
Immunic to Participate in Investor and Medical Conferences in May Regulatory Filings	2026-04-30	English
8-K - IMMUNIC, INC. (0001280776) (Filer) Regulatory Filings	2026-04-28	English
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer Board/Management Information	2026-04-28	English
8-K - IMMUNIC, INC. (0001280776) (Filer) Regulatory Filings	2026-04-23	English
Immunic, Inc. Announces 1-for-10 Reverse Stock Split Share Issue/Capital Change	2026-04-23	English
10-K/A - IMMUNIC, INC. (0001280776) (Filer) Annual Report	2026-04-22	English
8-K - IMMUNIC, INC. (0001280776) (Filer) Regulatory Filings	2026-04-14	English
S-8 - IMMUNIC, INC. (0001280776) (Filer) Registration Form	2026-04-09	English
Immunic to Participate in Scientific and Medical Conferences in April Regulatory Filings	2026-04-09	English
S-3 - IMMUNIC, INC. (0001280776) (Filer) Registration Form	2026-04-02	English
8-K - IMMUNIC, INC. (0001280776) (Filer) Regulatory Filings	2026-04-01	English
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement Regulatory Filings	2026-04-01	English
8-K - IMMUNIC, INC. (0001280776) (Filer) Regulatory Filings	2026-03-31	English
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton Board/Management Information	2026-03-31	English
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium Regulatory Filings	2026-03-10	English
Immunic to Participate in Investor Conferences in March Regulatory Filings	2026-03-03	English
DEF 14A - IMMUNIC, INC. (0001280776) (Filer) Proxy Solicitation & Information Statement	2026-03-02	English
10-K - IMMUNIC, INC. (0001280776) (Filer) Annual Report FY 2025	2026-02-26	English
8-K - IMMUNIC, INC. (0001280776) (Filer) Regulatory Filings	2026-02-26	English
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update Earnings Release FY 2025	2026-02-26	English
Immunic Announces Closing of Oversubscribed Private Placement Financing Capital/Financing Update	2026-02-17	English
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company Capital/Financing Update	2026-02-13	English
8-K Filing Regulatory Filings	2026-02-13	English
SCHEDULE 13G/A Filing Major Shareholding Notification	2026-02-13	English
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis Regulatory Filings	2026-02-04	English
SCHEDULE 13G/A Filing Major Shareholding Notification	2026-02-02	English
Immunic Highlights 2025 Accomplishments and Upcoming Milestones Regulatory Filings	2026-01-07	English
8-K Filing Regulatory Filings	2026-01-06	English
8-K Filing Regulatory Filings	2026-01-05	English

Filings by year

2026 29 filings
2025 75 filings
2024 73 filings
2023 39 filings
2022 66 filings
2021 48 filings
2020 59 filings
2019 78 filings
2018 52 filings
2017 59 filings
2016 46 filings
2015 46 filings
2014 72 filings
2013 22 filings
2012 4 filings
2011 4 filings
2010 5 filings
2009 3 filings
2007 1 filing
2006 1 filing
2005 2 filings
2004 2 filings